University at Albany researchers at the RNA Institute have developed a new method to test COVID-19 vaccine integrity that could allow anyone with basic skills in vaccine handling to detect expired vaccines quickly and effectively, without specialized lab equipment.
By employing laser-derived signals to assess vaccine stability, the method can be performed on sealed vials with no disruption to the vaccine’s therapeutic effects. The system could be contained in a portable unit for easy transport and handling.
The research marks an important advancement in mRNA vaccine technology and was featured on the January 2024 cover of Analytical Chemistry.
“Current methods for testing the integrity of mRNA-based vaccines are destructive, time-consuming, costly and require highly skilled personnel,” said collaborator Lamyaa Almehmadi, who led this study as a Ph.D. student at UAlbany’s RNA Institute and is now working as a postdoc at MIT.
“There is an unmet need for a quick and easy method to test the stability of mRNA vaccines distributed to vaccine clinics, medical offices and pharmacies worldwide. To the best of my knowledge, our method is the first to enable an in-situ, non-destructive and reagent-free approach for mRNA stability analysis in mRNA-based vaccines.”
When the first mRNA vaccines for COVID-19 were being rolled out, concerns quickly emerged around vaccine transport and storage. This is because the vaccines rely on active mRNA molecules that can degrade with prolonged exposure to sunlight and/or temperatures outside the range of minus 80 to minus 20 degrees Celsius.
Although mRNA vaccines pose special logistical challenges, the global public health community has successfully implemented systems to maintain optimal conditions for vaccine stability. With these systems in place, this new method can provide an additional layer of assurance to guarantee vaccine stability and bolster confidence in their efficacy.
Using lasers to assess vaccine stability
The method employs a unique Raman spectroscopy instrument developed by UAlbany’s Igor Lednev, the Williams-Raycheff Endowed Professor in the Department of Chemistry. The technique involves pointing an ultraviolet (UV) laser into a liquid, which creates scattered light that can be detected and analyzed, revealing chemical signatures.
Since its invention about 20 years ago, Lednev’s lab has adapted the technology, combined with advanced machine learning, for various applications including forensic science and disease detection.
In this latest application, Lednev’s team developed a way to detect small changes in mRNA structure that indicate loss of therapeutic functionality.
“Our method works by shining a deep-UV laser through a vial of vaccine and collecting the resulting scattered light,” said Almehmadi.
“This scattered light is then detected by our instrument, and our software processes it to yield the RNA signature, known as the Raman spectrum. The mRNA Raman spectrum is then used for RNA degradation analysis. The test is rapid, typically taking just a few minutes to complete.”
Compact tech to improve accessibility
Unlike existing methods used to test vaccine stability which require specialized training and must be conducted in a lab, this method can be fully contained in a handheld instrument. It is also non-invasive, so could be used to test multiple vials of vaccine, which, if found to be stable, could then be administered.
“Individuals with basic training in handling vaccine vials and operating the instrument could utilize our method effectively in a variety of settings outside a lab,” said Almehmadi.
“Furthermore, with the assistance of advanced software, the process of data collection and results interpretation can be automated, making it accessible to a wider range of users.”
“The technology that we’ve developed in this study is universal in several important ways,” said Lednev.
“It allows for obtaining mRNA spectral characteristics in situ without disintegrating the vaccine capsule. It is also nondestructive; should the test result be positive, the vaccine could then be used for the treatment. For these reasons, our novel technology might find numerous applications for testing the stability of various mRNA vaccines, and mRNA therapeutics in general.”
Lednev notes that this work was a collaborative, interdisciplinary effort made possible with the expertise of Alexander Shekhtman and Sergei Reverdatto, both in UAlbany’s Department of Chemistry, who designed and prepared the model vaccines used in this study and conducted biochemical tests to evaluate vaccine stability.
More information: Lamyaa M. Almehmadi et al, In Situ Stability Test for mRNA Vaccines Based on Deep-UV Resonance Raman Spectroscopy, Analytical Chemistry (2023). DOI: 10.1021/acs.analchem.3c01761
Journal information: Analytical Chemistry
Provided by University at Albany
News
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
